Luye Pharma Group Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Luye Pharma Group Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                         Luye Pharma Group Ltd. - Pharmaceuticals & Healthcare - Deals and
                                                 Alliances Profile
       Reference Code: GDPH222570D                                                                                                           Publication Date: JUN 2013

      Company Overview                                                                                        Key Facts
      Luye Pharma Group Ltd. (Luye Pharma) is a biopharmaceutical company. It focuses
                                                                                                              Luye Pharma Group Ltd., Pharmaceuticals &
      on the research, development, manufacture and commercialization of natural drugs,
                                                                                                              Healthcare, Key Facts
      novel formulations and biotechnology products. The company offers products
      indicated for treatment in various therapeutic areas such as, oncology,                                  Web Address                      www.luye.cn
      cardiovascular, orthopaedics, gastroenterology and central nervous system.Luye
                                                                                                               Revenue (US$ million)                           NA
      Pharma's commercial product portfolio comprises CMNa, Lipusu, Xuezhikang,
      Maitongna, Lutingnuo, Nuosen and others. It also exports active pharmaceutical                           Number of Employees                             NA
      ingredients (APIs) to international market. The company supplies its products to over                    GlobalData
      3500 hospitals across the country.

      Financial Deals Landscape
        Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deals                       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare,
        by Type, 2007 to YTD 2013                                                         Deals By Year, 2007 to YTD 2013


                                                                                                                 3
                                                                                                          3


                                                                                           No. of Deals
                                                                                                                          2              2      2        2
                                                                                                          2

                                                                                                                                    1
                                                                                                          1

                                                                                                                                                                   0
                                                                                                          0
                                                                                                               2007      2008    2009   2010   2011     2012   YTD
                                                                                                                                                               2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Luye Pharma Group Ltd., Pharmaceuticals & Healthcare,                            Luye Pharma Group Ltd., Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013

                         14     12
                                                                                                                     2          2
                         12
          No. of Deals




                                                                                           No. of Deals




                                                                                                          2
                         10
                          8
                          6                                                                                                              1          1          1
                                                                                                          1
                          4
                          2                0           0           0
                          0
                              Asia-      Middle     North       South                                     0
                              Pacific   East and   America       and                                            Immun         Metabol Central Gastroi Infectio
                                         Africa                Central                                           ology           ic   Nervou ntestin     us
                                                               America                                                        Disorde    s      al    Disease
                                                                                                                                 rs   System


         Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData
                                                                                          from 2006 onwards, GlobalData




Luye Pharma Group Ltd. - Pharmaceuticals & Healthcare - Deals                                                                                  Reference Code: GDPH222570D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .......................................................... 4
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................... 5
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013....................................................... 6
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................ 7
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................ 8
       Luye Pharma Group Ltd., Pharmaceuticals & Healthcare, Deal Details ............................................................................................. 9
          Partnerships.................................................................................................................................................................................... 9
             Shandong Luye Enters Into An Agreement With LG Life Sciences ............................................................................................. 9
          Licensing Agreements .................................................................................................................................................................. 10
             Luye Pharma Group Enters Into Licensing Agreement With Dong-A Pharma For DA-1229 ..................................................... 10
             Napo Pharma Enters Into Licensing Agreement With Luye Pharma ......................................................................................... 11
          Acquisition .................................................................................................................................................................................... 12
             A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million...................................................... 12
             Shandong Luye Pharma Completes Acquisition Of Sichuan Baoguang ................................................................................... 13
             Luye Pharma To Acquire Additional Stake In A-Bio Pharma From Biomedical Sciences ......................................................... 14
             Luye Pharma And Biomedical Sciences Invest In A-Bio Pharma .............................................................................................. 15
             AsiaPharm To Acquire Minority Stake In Beijing WBL Peking University Biotech ..................................................................... 16
             Shandong Luye Pharma Sells Guangzhou LifeTech Pharma ................................................................................................... 17
             Shandong Luye Divests Guangzhou Lifetech Jiuzhoutong ....................................................................................................... 18
             AsiaPharm Acquires 43% Stake In WBL Peking University Biotech ......................................................................................... 19
             AsiaPharm Acquires Solid Success Holdings ........................................................................................................................... 20
       Luye Pharma Group Ltd. - Key Competitors..................................................................................................................................... 21
       Key Employees ................................................................................................................................................................................ 22
       Locations And Subsidiaries .............................................................................................................................................................. 23
          Head Office ................................................................................................................................................................................... 23
          Other Locations & Subsidiaries ..................................................................................................................................................... 23
       Appendix .......................................................................................................................................................................................... 25
          Me
				
DOCUMENT INFO
Description: Luye Pharma Group Ltd. (Luye Pharma) is a biopharmaceutical company. It focuses on the research, development, manufacture and commercialization of natural drugs, novel formulations and biotechnology products. The company offers products indicated for treatment in various therapeutic areas such as, oncology, cardiovascular, orthopaedics, gastroenterology and central nervous system.Luye Pharma's commercial product portfolio comprises CMNa, Lipusu, Xuezhikang, Maitongna, Lutingnuo, Nuosen and others. It also exports active pharmaceutical ingredients (APIs) to international market. The company supplies its products to over 3500 hospitals across the country. Luye Pharma manages GMP/GLP certified production and R&D facilities located in Beijing, Nanjing, Yantai, Sichuan and Singapore. It operates through three reportable segments, namely, Oncology Drugs, Cardiovascular Drugs and Others. Luye Pharma is headquartered in Singapore. Luye Pharma Group Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Ty
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.